Dolasetron for the Prevention of CINV in Children With Acute Lymphoblastic Leukemia

NCT06756022 · clinicaltrials.gov ↗

RECRUITING

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Chemotherapy Induced Nausea and Vomiting

Interventions

DRUG: Dolasetron mesylate injection

Sponsor

Anhui Provincial Children's Hospital